Skip to main content

Leal Roca, Nuria

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Leal Roca, Nuria

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Maria Pallares Masmitja

Maria Pallares Masmitja

Postdoctoral researcher
Gene and Cell Therapy
Read more
Nuria Gonzalez Llorens

Nuria Gonzalez Llorens

Growth and Development
Read more
Aguado Lain, Carmen

Aguado Lain, Carmen

Shock, Organ Dysfunction and Resuscitation
Read more
Solsona Caravaca, Javier

Solsona Caravaca, Javier

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.